The Medical Letter on Drugs and Therapeutics
May 31, 2010
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
In Brief: Herpes Zoster Vaccine (Zostavax) Revisited
May 31, 2010 (Issue: 1339)The 2006 Medical Letter article on the then-new varicella-zoster vaccine concluded that Zostavax appears to be safe and effective in protecting patients ≥60 years old against herpes zoster and postherpetic neuralgia, especially in reducing the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.